US Stock MarketDetailed Quotes

ITCI Intra-Cellular Therapies

Watchlist
  • 72.300
  • -0.960-1.31%
Close Apr 29 16:00 ET
  • 72.300
  • 0.0000.00%
Post 16:20 ET
7.62BMarket Cap-49520P/E (TTM)

Intra-Cellular Therapies Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Apr 24, 2024

Based on 14 analysts giving stock ratings to Intra-Cellular Therapies in the past 3 months

Strong Buy

  • Buy

    85.71%

  • Hold

    14.29%

  • Sell

    0.00%

Price Target

Updated: Apr 24, 2024

The average Intra-Cellular Therapies stock price target is 94.46 with a max estimate of 120.00 and a min estimate of 75.00

Review Intra-Cellular Therapies earnings estimates

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Analysis

Analyst Rating

Updated: Apr 24, 2024

Strong Buy

  • Buy

    85.71%

  • Hold

    14.29%

  • Sell

    0.00%

Price Target

Updated: Apr 24, 2024

Heat List
US
Overall
Symbol
Latest Price
%Chg